BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03847428-completion@plaintrial.com
DTSTAMP:20261028T171947Z
DTSTART;VALUE=DATE:20270531
SUMMARY:Assess Efficacy and Safety of Durvalumab Alone or Combined With Bev
 acizumab in High Risk of Recurrence HCC Patients After Curative Treatment 
 — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT03847428
URL:https://plaintrial.com/trial/NCT03847428
END:VEVENT
END:VCALENDAR